Open access · Peer reviewed · No APCs
Review ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 54 | Issue 4 | 2020 | pp. 865–874Open access
Using Chloroquine and Hydroxychloroquine in the Treatment of COVID-19: Does It Make Sense?
- 1
- 1 Department of Organic Chemistry, Chemistry Institute, Federal University of Bahia, Salvador, Bahia, BRAZIL.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Email: ronbatis@ufba.br
Copyright: © 2020 Manuscript Technomedia. This is an open access article.
- Published:
- Dec 15, 2020
- Received:
- Jul 8, 2020
- Accepted:
- Oct 7, 2020
How to cite
Batista, R. (2020). Using Chloroquine and Hydroxychloroquine in the Treatment of COVID-19: Does It Make Sense? Indian Journal of Pharmaceutical Education and Research, 54(4), 865–874. https://doi.org/10.5530/ijper.54.4.179
Abstract
The severe acute respiratory syndrome caused by the new coronavirus SARS-Cov-2 (COVID-19) has quickly turned into a pandemic, infecting more than 10 million people and causing more than 500,000 deaths worldwide. The absence of an effective treatment against this disease has led several researchers to investigate the possibility of redirecting drugs already known to be effective against other diseases in the treatment of COVID-19, among them the antimalarial drugs chloroquine and hydroxychloroquine. This review aims at showing how chloroquine and hydroxychloroquine came to be considered as possible drugs in the treatment of COVID-19 and how the recent in vivo experiments described so far shed light on the adequacy of this use.
Keywords
Subject
Article metadata
| Title | Using Chloroquine and Hydroxychloroquine in the Treatment of COVID-19: Does It Make Sense? |
|---|---|
| Authors | Ronan Batista |
| Affiliations | Department of Organic Chemistry, Chemistry Institute, Federal University of Bahia, Salvador, Bahia, BRAZIL. |
| Corresponding author | ronbatis@ufba.br |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 54, Issue 4 (2020) |
Also in this issue
- Reduced Pharma Supply Chain in COVID-19: Measures to Reduce India’s Reliance for Active Pharmaceutical Ingredients on China and other Countriespp. 835–842
- Artificial Intelligence: A New Paradigm for Pharmaceutical Applications in Formulations Developmentpp. 843–846
- An Outbreak of Severe Acute Respiratory Syndrome-2019 (COVID-19): A Major Health Concernpp. 847–857
- Pharmaceutical and Biotechnological Importance of Actinobacterial Productspp. 858–864
- The Need for Simulated Patient Method Implementation in Pharmaceutical Education in Polandpp. 875–880
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026